Brigham and Women's Hospital, PBB-A4, 15 Francis Street, Boston, MA, 02115, USA.
Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Curr HIV/AIDS Rep. 2020 Oct;17(5):478-486. doi: 10.1007/s11904-020-00523-0.
Antiretroviral treatment (ART) can dramatically reduce the risk of HIV transmission, but the feasibility of scaling up HIV testing, linkage and treatment to very high population levels, and its impact on population HIV incidence, were unknown. We review key findings from a community-randomized trial in which we evaluated the impact of "universal test and treat" (UTT) on population HIV incidence in Botswana, a resource-constrained country with both high HIV prevalence and high ART coverage before study inception.
We conducted a community-randomized trial (the "Ya Tsie" trial or Botswana Combination Prevention Project (BCPP)) in 30 villages in Botswana from 2013 to 2018, with the goal of determining whether a combination of prevention interventions-with a focus on universal HIV testing and treatment-would reduce population-level HIV incidence. The intervention included universal HIV testing (home-based and mobile), active linkage to HIV care and treatment with patient tracing for persons not linking, universal ART coverage, rapid ART start (at the first clinic visit), and enhanced male circumcision services. Botswana had very high HIV diagnosis, treatment, and viral suppression levels (approaching the UNAIDS "90-90-90" targets) prior to intervention roll-out. By study end, we were able to exceed the overall 95-95-95 coverage target of 86%: an estimated 88% of all persons living with HIV were on ART and had viral suppression in the Ya Tsie intervention arm. In addition, annual HIV incidence was 30% lower in the intervention arm as compared with the control arm over a 29-month follow-up period. With universal HIV testing and relatively simple linkage activities, it was possible to achieve one of the highest reported population levels of HIV diagnosis, linkage to care, and viral suppression globally and to reduce population HIV incidence by about one-third over a short period of time (< 3 years). We were able to significantly increase population viral suppression and to decrease HIV incidence even in a resource-constrained setting with pre-existing very high testing and treatment coverage. Universal community-based HIV testing and tracing of individuals through the HIV care cascade were key intervention components.
抗逆转录病毒治疗(ART)可显著降低 HIV 传播风险,但扩大 HIV 检测、衔接治疗和治疗至极高人群水平的可行性及其对人群 HIV 发病率的影响尚不清楚。我们综述了一项社区随机试验的关键结果,该试验评估了“普遍检测和治疗”(UTT)对博茨瓦纳人群 HIV 发病率的影响,博茨瓦纳是一个资源有限的国家,在研究开始前就已经具有较高的 HIV 流行率和较高的 ART 覆盖率。
我们于 2013 年至 2018 年在博茨瓦纳的 30 个村庄开展了一项社区随机试验(“Ya Tsie”试验或博茨瓦纳组合预防项目(BCPP)),旨在确定预防干预措施的组合——重点是普遍的 HIV 检测和治疗——是否会降低人群 HIV 发病率。该干预措施包括普遍的 HIV 检测(家庭和流动)、积极将 HIV 感染者衔接至治疗并进行患者追踪,对未衔接者进行治疗、普遍提供 ART、快速开始 ART(在首次就诊时)以及增强男性包皮环切服务。在干预措施实施之前,博茨瓦纳的 HIV 诊断、治疗和病毒抑制水平非常高(接近联合国艾滋病规划署“90-90-90”目标)。到研究结束时,我们能够超过总体 95-95-95 覆盖率目标的 86%:在 Ya Tsie 干预组中,估计有 88%的所有 HIV 感染者正在接受 ART 治疗,并且病毒得到了抑制。此外,在 29 个月的随访期间,干预组的年度 HIV 发病率比对照组低 30%。通过普遍的 HIV 检测和相对简单的衔接活动,有可能在全球范围内实现报告的最高人群 HIV 诊断、衔接治疗和病毒抑制水平之一,并在较短的时间内(<3 年)将人群 HIV 发病率降低三分之一左右。我们能够显著提高人群病毒抑制率,并降低 HIV 发病率,即使在资源有限、已有很高检测和治疗覆盖率的情况下也是如此。基于社区的普遍 HIV 检测和通过 HIV 关怀级联追踪个人是关键的干预组成部分。